skip to content

Documents

 

CDC Releases Guideline for Prescribing Opioids for Chronic Pain - 2016
As part of the urgent response to the epidemic of overdose deaths, CDC issued new recommendations for prescribing opioid medications for chronic pain, excluding cancer, palliative, and end-of-life care.  

2016 Joint Statement on the Impact of Health Conditions and Medication Use on the Operation of Vehicles
The Boards of Medical Practice, Nursing and Pharmacy collaboratively developed and adopted a Joint Statement on the Impact of Health Conditions and Medication Use on the Operation of Vehicles.  The Joint Statement is meant to offer guidance to pharmacists and licensed healthcare providers who are authorized to prescribe medications. 

Press Release - Boards Adopt Joint Statement on the Impact of Health Conditions and Medication use on the Operation of Vehicles
The Minnesota Boards of Medical Practice, Nursing, and Pharmacy recently adopted a Joint Statement on the impact of health conditions and medications on the safe operation of vehicles.

2015 Joint Statement on Pain Management - Minnesota Boards of Medical Practice, Nursing, and Pharmacy
Pain management and opioid prescription drug abuse are significant issues in healthcare today. There is a critical balance between preventing opioid misuse and managing pain. In the United States, 46 people die from a prescription opioid overdose each day. In 2007, the cost of prescription opioid abuse was estimated at $55.7 billion. In 2013, the leading cause of death due to injury was drug overdose with 51.8% being related to prescription drugs.  Click the above link to read the full statement.

Press Release - Boards Adopt Updated Joint Statement On Pain Management, December 30, 2015
The Minnesota Boards of Medical Practice, Nursing, and Pharmacy recently updated their Joint Statement on Pain Management. The Boards adopted the first Joint Statement on Pain Management in 2004, which was reaffirmed in 2009, to give guidance regarding untreated or inadequately-treated pain. In 2015, the Boards again reviewed the issue of pain management to offer added guidance regarding appropriate prescribing with emphasis on the critical balance between pain management and the potential misuse of controlled substance medications. 

2014 Board of Medical Practice Lymes Disease Resolution

2010 Board of Medical Practice Lymes Disease Resolution 

back to top